LEXINGTON, Mass.--(BUSINESS WIRE)--Aug. 1, 2006--Critical Therapeutics, Inc. (NASDAQ: CRTX), a biopharmaceutical company engaged in the discovery, development and commercialization of products for respiratory, inflammatory and critical care diseases, will conduct a conference call at 5:00 p.m. (ET) Thursday, August 3, following the after-market release of its second-quarter 2006 financial results. Critical Therapeutics' President Frank Thomas will lead the call, during which senior management will discuss the Company's second-quarter financial results, additional corporate activities and upcoming milestones.
